AG
ALDR
Artal Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-850,000
| Closed | -$10M | – | 111 |
|
|
2019
Q2 | $10M | Buy |
850,000
+350,000
| +70% | +$4.12M | 0.4% | 42 |
|
|
2019
Q1 | $6.83M | Buy |
500,000
+300,000
| +150% | +$4.1M | 0.28% | 52 |
|
|
2018
Q4 | $2.05M | Buy |
+200,000
| New | +$2.05M | 0.08% | 69 |
|
|
2018
Q1 | – | Sell |
-500,000
| Closed | -$5.73M | – | 130 |
|
|
2017
Q4 | $5.73M | Hold |
500,000
| – | – | 0.09% | 34 |
|
|
2017
Q3 | $6.13M | Buy |
500,000
+200,000
| +67% | +$2.45M | 0.11% | 31 |
|
|
2017
Q2 | $3.44M | Hold |
300,000
| – | – | 0.06% | 53 |
|
|
2017
Q1 | $6.24M | Buy |
+300,000
| New | +$6.24M | 0.14% | 36 |
|